Correlation between soluble receptor for advanced glycation end products levels and coronary artery disease in postmenopausal nondiabetic women

Table 2 Univariate logistic regression analysis

Parameter	SE	P value	OR	95%CI for OR
				Lower	Upper
Age (yr)	0.038	0.374	1.034	0.960	1.115
HTN	0.598	0.742	0.821	0.254	2.651
BMI (kg/m²)	0.202	0.354	1.206	0.812	1.791
WC (cm)	0.126	0.152	0.835	0.653	1.069
FH CAD	0.668	0.011a	0.184	0.050	0.680
S. CHOL (mg/dl)	0.017	0.001b	1.060	1.025	1.096
S.LDL-C (mg/dl)	0.024	0.008b	0.938	0.895	0.983
S.HDL-C (mg/dl)	0.041	0.963	1.002	0.924	1.087
S.TG (mg/dl)	0.008	0.350	0.993	0.978	1.008
HC (μmol/L)	0.079	0.00b	0.725	0.621	0.847
Lp(a) (μg/mL)	0.002	0.041a	0.996	0.993	0.999
sRAGE (pg/mL)	0.001	0.010a	1.002	1.001	1.003
hsCRP (μg/mL)	1.037	0.00b	0.023	1.001	0.178

^aP < 0.05.

^bP < 0.01.

BMI: Body mass index; CAD: Coronary artery disease; CHOL: Cholesterol; CI: Confidence interval; HC: Homocysteine; HDL-C: High-density lipoprotein cholesterol; hsCRP: High-sensitive C-reactive protein. HTN: Hypertension; LDL-C: Low-density lipoprotein cholesterol; Lp(a): Lipoprotein(a); OR: Odds ratio; SE: Standard error; sRAGE: Soluble receptor for advanced glycation end products; TG: Triglycerides; WC: Waist circumference.